Adverse events after imatinib mesylate therapy

N Engl J Med. 2002 Feb 28;346(9):712-3. doi: 10.1056/NEJM200202283460919.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged
  • Antineoplastic Agents / adverse effects*
  • Benzamides
  • Female
  • Humans
  • Imatinib Mesylate
  • Leukemia, Myelomonocytic, Chronic / drug therapy
  • Middle Aged
  • Piperazines / adverse effects*
  • Primary Myelofibrosis / drug therapy
  • Pyrimidines / adverse effects*
  • Radiography
  • Splenic Rupture / chemically induced*
  • Splenic Rupture / diagnostic imaging
  • Splenomegaly / chemically induced
  • Splenomegaly / diagnostic imaging

Substances

  • Antineoplastic Agents
  • Benzamides
  • Piperazines
  • Pyrimidines
  • Imatinib Mesylate